Correlation Between Opus Genetics, and Vaccinex

Can any of the company-specific risk be diversified away by investing in both Opus Genetics, and Vaccinex at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Opus Genetics, and Vaccinex into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Opus Genetics, and Vaccinex, you can compare the effects of market volatilities on Opus Genetics, and Vaccinex and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Opus Genetics, with a short position of Vaccinex. Check out your portfolio center. Please also check ongoing floating volatility patterns of Opus Genetics, and Vaccinex.

Diversification Opportunities for Opus Genetics, and Vaccinex

-0.48

Correlation Coefficient

Opus Genetics,  Vaccinex

Very good diversification

The 3 months correlation between Opus and Vaccinex is -0.48. Overlapping area represents the amount of risk that can be diversified away by holding Opus Genetics, and Vaccinex in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vaccinex and Opus Genetics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Opus Genetics, are associated (or correlated) with Vaccinex. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vaccinex has no effect on the direction of Opus Genetics, i.e., Opus Genetics, and Vaccinex go up and down completely randomly.

Pair Corralation between Opus Genetics, and Vaccinex

Considering the 90-day investment horizon Opus Genetics, is expected to generate 0.46 times more return on investment than Vaccinex. However, Opus Genetics, is 2.18 times less risky than Vaccinex. It trades about 0.04 of its potential returns per unit of risk. Vaccinex is currently generating about -0.02 per unit of risk. If you would invest  127.00  in Opus Genetics, on October 6, 2024 and sell it today you would earn a total of  8.00  from holding Opus Genetics, or generate 6.3% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	93.65%
Values	Daily Returns

Opus Genetics,  vs.  Vaccinex

Opus Genetics,

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Opus Genetics, are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak basic indicators, Opus Genetics, exhibited solid returns over the last few months and may actually be approaching a breakup point.

Vaccinex

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Vaccinex has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Opus Genetics, and Vaccinex

The main advantage of trading using opposite Opus Genetics, and Vaccinex positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Opus Genetics, position performs unexpectedly, Vaccinex can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vaccinex will offset losses from the drop in Vaccinex's long position.

The idea behind Opus Genetics, and Vaccinex pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.